trial · primary record
Entrectinib
High Grade Glioma
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 52 |
| Primary completion | 2032-11 |
| Primary endpoint | Overall response rate (ORR) (Cohort 1) |
| Registry ID | NCT06528691 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:55:53.275Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06528691
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Entrectinib · approval
- Entrectinib · compound